The proposed facility aims to expand advanced cancer education, clinical trials, multidisciplinary treatment and international research collaboration.
Experts speak at a seminar on modern treatment strategies for head and neck cancer at Bangladesh Medical University in Dhaka on 16 November. Photo: Courtesy
“>
Experts speak at a seminar on modern treatment strategies for head and neck cancer at Bangladesh Medical University in Dhaka on 16 November. Photo: Courtesy
Bangladesh Medical University (BMU) plans to establish a specialised cancer research institute to strengthen higher education, research, clinical trials and multidisciplinary cancer care in the country.
Prof Dr Mujibur Rahman Hawlader, the university’s pro-vice-chancellor for Research and Development, disclosed the initiative at a central seminar titled “Head and Neck Cancer Today: Burden, Trends, and Modern Treatment Strategies” at Shaheed Dr Milon Hall on the BMU campus in Dhaka today (16 November).
He said the university already had specialised cancer departments, experienced faculty members, physicians and researchers. The proposed institute would bring these existing capacities together under a modern, integrated facility.
It is expected to create opportunities to expand advanced cancer education, research, clinical trials, multidisciplinary treatment and international collaboration, he added.
Prof Mujibur Rahman also referred to a recent joint imPACT Review Mission in Bangladesh involving the International Atomic Energy Agency (IAEA), the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC).
The mission assessed the country’s capacity in cancer prevention, screening, diagnosis, treatment, education, research and infrastructure. Its findings are expected to help identify priorities for improving cancer care, he said.
At the seminar, experts said head and neck cancer treatment was no longer limited to surgery. Depending on the type and stage of the disease, a combination of radiotherapy, chemotherapy, immunotherapy and targeted therapy could offer more effective and personalised treatment options.
In the first scientific session, Prof Dr Md Abdus Sattar, head of the Head and Neck Surgery Division at BMU’s Department of Otolaryngology–Head and Neck Surgery, presented a paper on the burden, trends and modern treatment strategies for head and neck cancer.
He highlighted the importance of timely diagnosis, accurate staging and selecting appropriate treatment methods.
In the second session, Prof Dr Syed Md Akram Hossain, chairman of BMU’s Department of Clinical Oncology, said advanced radiotherapy techniques, including intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), allow radiation to be delivered more precisely to cancer-affected areas.
These technologies can help reduce damage to surrounding healthy organs while improving treatment effectiveness, he said.
He also said findings from recent international clinical trials, particularly KEYNOTE-689, had opened up new possibilities for using immunotherapy before and after surgery in selected patients. Immunotherapy was also playing an important role in treating recurrent and metastatic cancers, he added.
Prof Akram Hossain said cancer treatment should not focus solely on controlling the disease or extending patients’ lives. Preserving their ability to speak, eat and swallow, as well as maintaining their quality of life, was equally important.
He stressed the need for treatment plans developed by multidisciplinary teams involving surgeons, oncologists, radiologists and pathologists.
He also called for expanding advanced radiotherapy technology, developing skilled manpower, strengthening physician training and increasing research in Bangladesh.
The seminar was chaired by Prof Dr Afzalun Nessa, chairperson of the Central Seminar Sub-Committee. University teachers, physicians and residents attended the event.
